{"url_path":"/sec/mlys/8-k/2026-08-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1933414/0001933414-26-000112-index.html","accession_number":"0001933414-26-000112","cik":"0001933414","ticker":"MLYS","issuer_name":"Mineralys Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1933414/0001933414-26-000112-index.html","primary_entity_key":"0001933414","primary_entity_name":"Mineralys Therapeutics, Inc."},"word_count":98,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit\nNo.Description\n\n[1](mlys2026q28kex101.htm)[0.1](mlys2026q28kex101.htm)\n\nAmendment to Amended and Restated Employment Letter Agreement, dated August 5, 2026, by and between David Rodman, M.D., and the Company\n\n[99.1](mlys2026q28kex991.htm)\n\nPress Release Issued on August 11, 2026\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDated: August 11, 2026MINERALYS THERAPEUTICS, INC.\n\nBy:/s/ Jeffrey A. Munsie\n\nName:Jeffrey A. Munsie\n\nTitle:Chief Legal Officer"}